.Surge Life Sciences has actually met its objective in a Duchenne muscle dystrophy (DMD) research st...
.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, taking...
.Achilles Rehabs has shreded its strategy. The English biotech is knocking off on its clinical-phase...
.Aligos Therapies is actually advertising a midstage win in metabolic-dysfunction linked steatohepat...
.Basilea Pharmaceutica's work creating brand new antifungals has actually received a notable increas...
.Possessing presently gathered up the U.S. legal rights to Capricor Therapies' late-stage Duchenne m...
.After pushing back the decision meeting for Applied Therapeutics' metabolic ailment drug govorestat...
.Novo Nordisk is continuing its own press into hereditary medicines, accepting to pay NanoVation The...
.Innovent Biologics has actually produced the case that its own gate inhibitor-cytokine blend health...
.A phase 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...